Showing posts sorted by relevance for query UK Million Women. Sort by date Show all posts
Showing posts sorted by relevance for query UK Million Women. Sort by date Show all posts

Wednesday, June 15, 2022

The UK Million Women Study of Cell Phone Use and Brain Tumor Risk

Journal of the National Cancer Institute publishes two letters critical of
UK Million Women Cell Phone/Brain Tumor Study


RE: Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study

Moskowitz, Joel M. RE: Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study. JNCI: Journal of the National Cancer Institute, 2022. doi: 10.1093/jnci/djac109.

No abstract

Excerpts

"Like the Danish Cohort study (1), the recent paper by Schüz et al. (2) which examined cellular telephone use and brain tumor risk in the Million Women Study suffered from poor exposure assessment which likely contributed to exposure misclassification. Moreover, participant attrition in this study was high (68%), and the study was underpowered as the analysis sample included few participants with heavier cell phone use, the group with the greatest brain tumor risk (2)."

"Although the Schüz et al. paper (2) provides sound advice to 'reduce unnecessary exposures,' the abstract in this paper is a disservice to public health because it ends with a misleading assertion: 'Our findings support the accumulating evidence that cellular telephone use under usual conditions does not increase brain tumor incidence.'  How can the authors of this paper argue that their results apply to 'usual conditions' when the amount of cell phone use in their analysis sample was much less than 'usual' for the United Kingdom (UK)?"

"... a recent meta-analysis of 46 case-control studies (6) found significantly increased brain tumor incidence with cumulative call time ≥ 1,000 hours (about 17 minutes per day over a 10-year period). Furthermore, Philips et al. (7) examined brain tumor incidence in England from 1995-2015 and found a two-fold increase in the standardized incidence of the most common malignant brain tumor, glioblastoma multiforme, along with reduced incidence of lower grade brain tumors which could indicate a tumor promotion effect from the increased uptake in cell phone use during this time period."

"In sum, the Schüz et al. study (2) provides no assurance of safety from brain tumors for most cell phone users, especially those who start using cell phones at a younger age than the middle-aged and elderly women who participated in this study."


--

RE: Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study

Birnbaum, Linda S, Taylor, Hugh S, Baldwin, Hillel, Ben-Ishai, Paul, Davis, Devra. RE: Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study. JNCI: Journal of the National Cancer Institute, 2022. doi: 10.1093/jnci/djac110.

No abstract

Excerpts

"... a recent analysis of self-reported cell phone use of this original cohort by Shuz et al. 1 contains a number of serious errors and flaws of exposure measurement that undermine the validity of their widely publicized finding purporting that there is no risk of brain cancer from cell phone radiofrequency radiation (RFR) 1."

"Further, the National Toxicology Program (NTP) and Ramazzini Institute (RI)  experimental animal studies are inaccurately criticized as based on small numbers, inconsistency across species, and excessively high exposures 3,4."

"Current outdated regulatory limits for phone RFR rest on the incorrect long held assumption that non thermal levels are safe."

"The majority of animal and cell studies have found nonionizing RFR can induce oxidative stress- a key characteristic of human carcinogens and a way that RFR can initiate or promote tumor development as well as play a role in the development of other diseases 5.

Recent experimental and epidemiological studies indicate that RFR also induces cancers of the thyroid and breast 6,7. DNA damage and cancer in these state of the art studies signal the need for the public to reduce exposures to RFR now."


--

Response to Moskowitz and Birnbaum, Taylor, Baldwin et al.

Schüz, Joachim, Pirie, Kirstin, Reeves, Gillian K, Floud, Sarah, Beral, Valerie. Response to Moskowitz and Birnbaum, Taylor, Baldwin et al. JNCI: Journal of the National Cancer Institute. 2022. doi: 10.1093/jnci/djac111.

No abstract

Excerpts

" We do agree, however, with both Moskowitz (1) and Birnbaum et al. (6) that our study does not include many heavy users of cellular phones."

"A large international prospective study of cellular telephone users including also men and younger women is underway [7] but results have not been published yet. Overall, our findings and those from other studies support our carefully worded conclusion that 'cellular telephone use under usual conditions [our emphasis] does not increase brain tumor incidence'. However, advising heavy users on how to reduce unnecessary exposures remains a good precautionary approach."


--

March 30, 2022 (Updated April 1, 2022)

Cellular Telephone Use and the Risk of Brain Tumors: 
Update of the UK Million Women Study

Joachim Schüz, Kirstin Pirie, Gillian K Reeves, Sarah Floud, Valerie Beral, for the Million Women Study Collaborators. Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study. JNCI: Journal of the National Cancer Institute, Volume 114, Issue 5, May 2022, Pages 704–711, doi: 10.1093/jnci/djac042.

Abstract

Background

The ongoing debate of whether use of cellular telephones increases the risk of developing a brain tumor was recently fueled by the launch of the fifth generation of wireless technologies. Here, we update follow-up of a large-scale prospective study on the association between cellular telephone use and brain tumors.

Methods

During 1996-2001, 1.3 million women born in 1935-1950 were recruited into the study. Questions on cellular telephone use were first asked in median year 2001 and again in median year 2011. All study participants were followed via record linkage to National Health Services databases on deaths and cancer registrations (including nonmalignant brain tumors).

Results

During 14 years follow-up of 776 156 women who completed the 2001 questionnaire, a total of 3268 incident brain tumors were registered. Adjusted relative risks for ever vs never cellular telephone use were 0.97 (95% confidence interval = 0.90 to 1.04) for all brain tumors, 0.89 (95% confidence interval = 0.80 to 0.99) for glioma, and not statistically significantly different to 1.0 for meningioma, pituitary tumors, and acoustic neuroma. Compared with never-users, no statistically significant associations were found, overall or by tumor subtype, for daily cellular telephone use or for having used cellular telephones for at least 10 years. Taking use in 2011 as baseline, there were no statistically significant associations with talking for at least 20 minutes per week or with at least 10 years use. For gliomas occurring in the temporal and parietal lobes, the parts of the brain most likely to be exposed to radiofrequency electromagnetic fields from cellular telephones, relative risks were slightly below 1.0.

Conclusion

Our findings support the accumulating evidence that cellular telephone use under usual conditions does not increase brain tumor incidence.

Open access paper: https://bit.ly/UKwomen2022

--

Preliminary comments on "Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study"

Like the earlier cell phone-brain tumor risk study that used data from the UK Million Women study (Benson et al., 2013), the current study (Schüz et al., 2022) is methodologically unsound due to limited assessment of cell phone use over time and misclassification of exposure. Furthermore, participant attrition from this prospective longitudinal study was very high which likely contributed to the fact that few participants in the main analysis were heavy lifetime cell phone users.

Thus, the study provides no assurance of safety to current cell phone users who use their phones more or start using at a younger age. The results of this study are also limited to the study population, namely middle-aged and elderly women who lived in the United Kingdom (UK).

Comparing their study to Interphone, a 13-nation case-control study which found that heavy lifetime use of cell phones (1,640 or more hours -- the top decile or 10%) was associated with significantly increased malignant brain tumor (i.e., glioma) incidence, the authors point out a major limitation of their new study:

"In INTERPHONE, a modest positive association was seen between glioma risk and the heaviest (top decile of) cellular telephone use (odds ratio = 1.40, 95% CI = 1.03 to 1.89). This specific group of cellular telephone users is estimated to represent not more than 3% of the women in our study, so that overall, the results of the 2 studies are not in contradiction (23)."

In the current study, only 18% of cell phone users talked on cell phones more than 30 minutes per week which corresponds to about 4 minutes per day or 26 hours per year which amounts to about 260 hours over a 10-year period -- far less use than what it would take to see a statistically significant association with brain tumor incidence. Even among daily cell phone users in this study, only 41% talked on their cell phones more than 30 minutes per week.

In contrast, we found in our meta-analysis of 46 case-control studies that "cellular phone use with cumulative call time more than 1000 hours statistically significantly increased the risk of tumors" which corresponds to at least 17 minutes per day over a 10-year period (Choi, Moskowitz et al., 2020).

The study also misclassified some "never" and "ever" users: Among participants who completed the 2001 and 2011 surveys, 45.8% of the 2001 never users talked on cellphones more than 1 minute per week (vs. 73.5% of ever users), and 8.8% talked on their cellphones more than 30 minutes per week (vs. 18.2% of ever users). 2001 never users talked on their cellphones an average of 4.3 years (vs. 8.9 years for ever users).

The current study did not control for cordless phone use, a potential confounder, which likely increases brain tumor risk. The study also failed to control for those who kept the cellphone away from their head during phone call phones by using the speaker phone or a headset.

The authors did not report any analyses to determine whether the selection of participants for this study or the high amount of participant attrition (68%) biased the study results.

The paper reported, "For the main malignant subtypes, glioma and glioblastoma, there was no indication of an increase, based on 937 and 702 cases, respectively, in cellular telephone users." 

How can the authors account for the results found in a study that examined brain tumor incidence from 1995 to 2015 in England (which includes about 84% of the UK population, the sampling frame for the current study)?  Philips et al., 2018 found a substantial increase in the incidence of the most common form of glioma, glioblastoma multiforme (GBM), over that time period along with a reduced incidence of lower grade tumors:

"We report a sustained and highly statistically significant ASR [age-standardized incidence rate] rise in glioblastoma multiforme (GBM) across all ages. The ASR for GBM more than doubled from 2.4 to 5.0, with annual case numbers rising from 983 to 2531. Overall, this rise is mostly hidden in the overall data by a reduced incidence of lower grade tumours."

This new paper concludes with the following advice: 

"Future research should target specifically the very heavy cellular telephone users, with attention to new features of a continuously evolving technology; hence, advising cellular telephone users on how to reduce unnecessary exposures remains a good precautionary approach."

Unfortunately, those who only read the abstract will see the following disingenuous conclusion:

"Our findings support the accumulating evidence that cellular telephone use under usual conditions does not increase brain tumor incidence."

The phrases, "accumulating evidence" and "under usual conditions" seem misleading given the limitations of the current study. Moreover, multiple case-control studies report increased brain tumor incidence with levels of cell phone use now considered quite common. The U.S. National Cancer Institute should be admonished for publishing this study in their hallmark journal, JNCI.

--

No Link Between Cell Phones and Brain Tumors in Large UK Study

Thursday, October 3, 2013

Million Women Study: Shoddy Science Does Not Warrant Shoddy Conclusions


Dr. Leszczynski is one of the world's leading biologists who researches the effects of radiofrequency radiation for the Finnish government. At least he did until the Finnish government defunded his laboratory.  He was one of 31 experts invited in 2011 by the World Health Organization's (WHO) International Agency for Research on Cancer to review the cancer risks of exposure to wireless radiation. The results of this expert review was that WHO classified radiofrequency energy, especially cell phone radiation, as "possibly carcinogenic" in humans (i.e., Group 2B). Dr. Leszczynski has subsequently reported that some of the group wanted a "probably carcinogenic" or Group 2A classification.

Dr. Leszczynski has been writing an occasional column that is published on the Washington Times web site.  For his latest article, he asked six experts including two of the WHO Interphone Study investigators to comment on the United Kingdom's Million Women Study.  His interest in this study is because the study's authors interpreted the absence of evidence for increased brain cancer risk to mean that cell phone radiation does not cause cancer.

One of the experts interviewed for this column was the former director of the WHO's EMF Project. He defends the Million Women Study and argues based on the results that cell phone radiation does not cause cancer.  In contrast, the other five experts including myself criticize the study and dismiss its relevance to the cancer debate.

Despite its shortcomings, the study found significant evidence that cell phone use was associated with increased risk of acoustic neuroma, a rare, non-malignant tumor on the nerve from the ear to the brain.


The Million Women Study … shoddy design … shoddy results … shoddy conclusions

Dariusz Leszczynski, Washington Times Communities, Oct 3, 2013

HELSINKI, Finland, October 3, 2013 —The only two epidemiological cohort studies in existence examining the link between cell phone radiation exposures and brain cancer have embarrassingly poor design.

The two cohorts were established in Denmark and in UK. The original purpose was not to study cell phone radiation effects but other health problems. At some point in designing cohorts, scientists decided to ask questions about cell phone use and, as an aside, to examine brain cancer risk.

The problem is that the questions concerning cell phone use were not well thought out. It seems that epidemiologists did not care at all about details of exposure to cell phone radiation. They just wanted to know it - “roughly”.

In the first cohort, called ‘Danish Cohort’, the information on exposure of persons to cell phone radiation is completely useless for the purpose of determining whether causality exists between radiation exposure and cancer (for details see letters to the British Medical Journal and The Scientist Magazine story).

In the spring of 2013, the results from the second cohort were published  and called The Million Women Study. As seen from the description of the study, its primary goal was to examine the effects of hormone replacement therapy in women over 50 years of age.

This, by design, indicates that the results of this study apply only to a certain sex (females) and age (over 50) group and can not be freely extrapolated to the cell phone users as a whole. Furthermore, period of the exposure to cell phone radiation examined in The Million Women Study is far too short to be relevant when examining causality link between cell phone radiation and cancer.

The information about cell phone radiation exposures obtained for the study was as follows (quote from the study): “Women in the study have been asked twice about mobile phone use. In a survey conducted between 1999 and 2005 (to which about 65% of women recruited in 1996–2001 replied [sic!]), women were asked: ‘About how often do you use a mobile phone?’, and given three options to respond: ‘never’, ‘less than once a day’, ‘every day’; and ‘For how long have you used one?’ (participants were asked to provide total years of use).”

The authors did not obtain information about cell phone usage per day or week. Cell phone users talking on the phone for few minutes or for few hours per week were analyzed together. When considering the latency of brain cancer, the follow-up period was far too short to provide relevant and reliable information. This extremely limited information about the exposures to cell phone radiation is absolutely inadequate to determine whether exposures have, or have not, causal link with cancer.

The inadequacy of the collected the information on the exposure is very disturbing. It is like scientists evaluating the health risk in smokers and not asking how many cigarettes per day someone smokes.

The Million Women Study has shoddy exposure design leading to shoddy results and ending with shoddy conclusions.

The Million Women Study is, similarly with the Danish Cohort, yet another example of the complete failure of epidemiologists to design scientifically relevant study on cell phone radiation and brain cancer.

It is embarrassing to hear that some scientists consider the “epidemiological failure”, called The Million Women Study, as a “well designed” research.

Forbes’ Magazine blogger, Geoffrey Kabat of the Albert Einstein College of Medicine in New York City, in his recent post says about The Million Women Study: “The strengths of this design are two-fold.  First, it follows the actual temporal sequence, with exposure preceding disease.  Second, since information on exposure is obtained before the onset of illness, this information cannot be biased (distorted) by the presence of illness.”

Indeed, these could be the strengths of the study if the information on exposures was relevant.

Mr. Kabat writes also that: “Because of its large size and prospective design, the Million Women Study results represent an important contribution.”

Big is not always beautiful, especially when one side of the examined equation, the radiation exposure data, are shoddy.

I asked also opinions from the few prominent scientists about The Million Women Study. Here are their opinions, directly as provided via e-mails:

Michael Repacholi, retired Head of the WHO EMF Project, agrees with Geoffrey Kabat that the Million Women Study is a valuable proof of no cancer risk:

“This is a very large, well-conducted cohort study showing no increased incidence of glioma or meningioma with mobile phone use of 10 or more years. However, the study reported a trend of increasing risk of acoustic neuroma. When the results were combined with the Danish cohort study, that had a much larger number of these tumours, no statistical increase was found with mobile phone use of 10 or more years. Aside from the obvious difficulties in accurately assessing people’s exposure to mobile phones, the evidence from well-conducted epidemiological and animal studies is now establishing that mobile phone use does not cause or increase the incidence of head or neck cancers.”

The above opinion of Michael Repacholi should be also viewed in the context of his recent criticism of epidemiology. His opinion was that epidemiology is unable to provide reliable information on causality link between cell phone radiation and brain cancer. As Mr. Repacholi said in his Guest Blog on BRHP: “my concern is that there is an over-reliance on epidemiology studies.”

However, epidemiologists were cautious and did not consider the evidence provided by The Million Women Study to be as great as Kabat and Repacholi thought.

Michael Kundi of the Medical University of Vienna, Austria, considers it a very good idea to use the existing large cohorts to study cell phone radiation and cancer issue. However, he points out that the authors of the Million Women Study did not do a good job:

“It is definitely worthwhile to try and use a large cohort of people that are available for investigations like the cohort of the Million Women Study. This cohort has been used for many important health issues and will continue to be used for a variety of research questions. Having said this, I regret to say that the authors have not put much thought into the issue of mobile phone use and brain tumors. It is almost impossible to study induction of brain tumors because of the short observation period. That is, most if not all of the tumors diagnosed during the follow-up must have already existed at the time of commencing use of a mobile. This leaves us with studying effects on tumor growth rate and/or progression. In the case of glioma the peculiarities of the relationship of incidences with age have to be considered. In this cohort there are only women and they are in a narrow age range of about 60 years. The consequence of this fact is that if mobile phone use leads to an increased growth rate of the tumor and therefore an earlier diagnosis the risk estimate must be low or even less than one (because at older age the incidence is declining). The situation for acoustic neuroma is different because the age-incidence function differs from that of glioma.”

Bruce Armstrong of the Sydney University, Australia, considers that The Million Women Study is insufficient to think of down-grading the IARC classification of cell phone radiation from the current possible carcinogen category to lower one:

“A total of 1,261 primary intracranial neoplasms were diagnosed during follow-up, which is sufficient to make a potentially worthwhile contribution to literature on mobile phone use and brain tumours. Some 50,000 invasive neoplasms at other sites were also diagnosed, which can also contribute to knowledge about the relationship between other cancers and mobile phone use. Of the intracranial tumours investigated (glioma, meningioma, pituitary tumours and acoustic neuroma) only risk of acoustic neuroma was increased in women who were longer term users of a mobile phone. This result is coherent with results from the most recent case-control studies of mobile phone use and acoustic neuroma but not with the absence of increase in risk of acoustic neuroma reported from the Danish cohort study of mobile phone subscribers.  While this study adds to the evidence on the relationship between mobile phone use and intracranial tumours, it does not add sufficiently, in my opinion, to shift in either direction the IARC’s conclusion that there is limited evidence in humans for carcinogenicity of radiofrequency radiation.”

Joel Moskowitz of the University of California at Berkeley has also serious doubts about the design and quality of the outcome of The Million Women Study:

“With regard to investigating the association between cell phone use and subsequent tumor risk (which was not the primary purpose of the “million women” study), this study had several major shortcomings which would undermine its ability to find this association.  First, cell phone use was measured only at the beginning of the study, and it was assessed too crudely to expect to find an association with tumor risk. When women enrolled in the study, they were asked how many years they used a cell phone, and if they did, whether they used it daily or less than daily. The researchers had no follow up assessments to determine whether the women continued to use their cell phones over time so they had to assume that cell phone users continued to use their cell phones. More importantly, the researchers could not assess how much time the women spent on a cell phone either before or during the course of the study so women who used a few minutes almost every day at baseline would be lumped together with women who used their phone a half hour or more per day.  Second, the study failed to assess cordless phone use which likely exceeded cell phone use among these women due to the high cost of cell phone minutes during this period.  Cordless phone use has been found in other research to increase brain tumor risk. Third, brain tumors can take several decades to develop and few women in this study had used their cell phones for ten or more years.  Fourth, about 40% of the 1.3 million women who participated in the study were excluded from the cell phone analyses—most because they failed to provide any cell phone information. This large loss of research participants limits how generalizable the study findings are and could have biased the results. Despite these major shortcomings, the study reported a statistically significant doubling of risk of acoustic neuroma, a tumor on the nerve from the ear to the brain, among those who used cell phones for 10 or more years. Moreover, this association was related to the number of years of cell phone use.”

Mark Elwood, of the University of Auckland in New Zealand is not convinced that the provided evidence is sufficiently reliable to convince the scientists and the general public alike:

“These scientists took the opportunity of asking a few questions about cell phone use in the huge British ‘Million Women’ study, where women attending breast cancer screening clinics were invited. Over the next 10 or more years, women (average age 59) who reported the most use of cellphones had the same risk of developing brain cancers than women who did not use cellphones  at the time that was asked (and also, the same risk of all cancers, and of 18 major types of cancer). So, another of many studies showing no risk from using cellphones, but like all other studies, it can’t prove that there’s no risk. In the many analyses, there was an increased risk of one rather rare tumor, based on only 8 cases; but that was acoustic neuroma, a tumor of the nerve to the ear, and therefore in the high exposure zone from cellphones. And the study doesn’t cover men, younger people, or risks beyond about 10 years. So the debate will continue.”


Elisabeth Cardis, of CREAL-Centre for Research in Environmental Epidemiology in Spain and formerly Principal Investigator of the Interphone Project, is cautious and considers results of The Million Women Study as too weak:

“Am a bit surprised at the lack of mention of the acoustic neuroma results in the conclusion - particularly since this and glioma are the two tumour types for which their is currently the most evidence from other studies (including Interphone and the Japanese study). It seems that the first questionnaire about mobile phone use was asked over a long time period 1999-2005 but the follow-up is correctly calculated from the time the questionnaire was asked. Of the 1261 intracranial CNS tumours, 754 occurred among those who reported ever use at first questionnaire.

Only 90 of these, however, were among women who reported using the phone every day and 100 among those who reported 10+ years of use. Numbers get even smaller when the first 3 years of follow-up are excluded - 91 with 10+ years. It would be nice to see results by some form of amount of use, but obviously the information collected is very limited - ever use, daily use and number of years - but perhaps looking at categories of daily use in different periods of time since start … but the numbers would get very small.”

From the above comments of prominent epidemiologists the general conclusion can be drawn that despite the size of The Million Women cohort, the numbers of tumors are small and the information about the cell phone use is nonexistent. Therefore, it is not possible to draw any scientifically reliable conclusions based on the results of The Million Women Study.

Setting up large cohort for epidemiological study is expensive and laborious. That is why it is indeed a very good idea to use the already existing cohorts to examine causality link between cell phone radiation exposures and brain cancer.

However, the radiation exposure information, both the length and the strength/intensity of exposure, must be properly collected. Scientists working on the Danish Cohort and The Million Women Study, failed in the study design. Radiation exposure information collected in both cohorts is shoddy.

It is very disappointing that yet again epidemiologists failed. They used funds to provide us with shoddy studies. What is very worrying is the fact that these studies were published in peer-review journals and are now considered, by some, as “reliable scientific evidence”.

It is simply an embarrassing show of scientific incompetence.




Friday, May 10, 2013

Cell Phone Use, Acoustic Neuroma and Cancer of the Pituitary Gland


Cell phone use was associated with increased risk of two types of brain tumors in a new study of 790,000 women.

BERKELEY, Calif. - May 10, 2013 - PRLog -- Cell phone use was associated with increased risk of acoustic neuroma and cancer of the pituitary gland in a prospective study of more than 790,000 women in the United Kingdom. (1)

Acoustic neuroma is a rare, non-malignant tumor that develops on the main nerve leading from the inner ear to the brain. The pituitary gland is an organ that produces hormones which regulate important functions of the body and is located in the middle of the base of the brain.

Women who used cell phones for ten or more years were two-and- a-half times more likely to develop an acoustic neuroma. Their risk of acoustic neuroma increased with the number of years they used cell phones.

The results for acoustic neuroma re-affirm one of the two major conclusions by the World Health Organization (WHO) in its recent monograph about radiofrequency electromagnetic fields and form the basis for classification of cell phone radiation as "possibly carcinogenic" to humans:

“Positive associations have been observed between exposure to radiofrequency radiation from wireless phones and glioma, and acoustic neuroma.” (p. 421) (2)

The risk of cancer of the pituitary gland more was more than twice as high among women who used a cell phone for less than five years as compared to never users. Although the risk was elevated for women who used a cell phone for ten or more years (about 60% greater than never users), this effect was not significant. Since this may be the first study to find an association between cell phone use and pituitary cancer, further research on this cancer is necessary.

The women reported their cell phone use in 2005 to 2009 and again in 2009 and were followed through 2011 to see whether they developed tumors. The analyses controlled for other factors associated with tumor risk.

The study had numerous weaknesses which may explain why the research failed to replicate the increased risk of glioma associated with cell phone use of ten or more years found in several previous studies. Although this was a prospective study, the assessment of cell phone use was poor. Cell phone use was measured only at two time points and in a crude manner. The authors considered anyone who used a cell phone at least a minute per week to be a cell phone user. Although the authors measured the amount of cell phone use per week at follow-up, they did not report these results.The study did not assess cordless phone use or other microwave radiation exposures that are similar to cell phone emissions. If the never-cell phone users were cordless phone users, the effect of cell phone use on brain tumor risk would have been underestimated.

Since brain tumors can take decades to develop, the study underestimates the long term risk due to cell phone use as the average follow-up period for cell phone users was only seven years. Few women (about 8%) in this study used cell phones for ten or more years. Moreover, the women in this study may have used their cell phones much less than women do today.

The study was published online in the International Journal of Epidemiology on May 8, 2013. The authors are affiliated with the University of Oxford and the World Health Organization’s International Agency for Research on Cancer.

Also see: U.K. Cell Phone Study Points to Acoustic Neuroma, Not Brain Cancer, Risk: Fourth Study to Show Tumor Link, Microwave News, Updated May 11, 2013

http://microwavenews.com/uk-study-points-acoustic-neuroma

References

(1) Benson VS, Pirie K, Schüz J, Reeves GK, Beral V, Green J; for the Million Women Study Collaborators.Mobile phone use and risk of brain neoplasms and other cancers: prospective study. Int J Epidemiol. 2013 Jun;42(3):792-802. doi: 10.1093/ije/dyt072. https://www.ncbi.nlm.nih.gov/pubmed/23657200 

(2) Non-ionizing radiation, Part II: Radiofrequency electromagnetic fields. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2011: Lyon, France). Vol. 102. 2013. http://monographs.iarc.fr/ENG/Monographs/vol102/index.php

Friday, November 22, 2024

International Agency for Research on Cancer (WHO) Position on Radiofrequency Radiation

Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2025–2029 

Radiofrequency electromagnetic fields including wireless mobile radiation (pp. 171-173)

Current IARC/WHO classification

Radiofrequency electromagnetic field (RF-EMF) radiation (including from wireless mobile telephones) has been previously classified by IARC as possibly carcinogenic to humans (Group 2B) in IARC Monographs Volume 102 in 2011 (IARC, 2013a), based on limited evidence in humans for glioma and acoustic neuroma. RF-EMF was given a priority rating of high by the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 (IARC, 2019a), on the basis of new cancer bioassay evidence in two independent studies (described below).

WHO is undertaking a health risk assessment of RF-EMF for a variety of outcomes, including cancer. This will be published as a monograph in the Environmental Health Criteria series and is based on several, currently ongoing, systematic reviews commissioned by WHO (Lagorio et al., 2021; Mevissen et al., 2022).

Exposure characterization

In IARC Monographs Volume 102, RF-EMF radiation was defined as radiation in the frequency range 30 kHz to 300 GHz (IARC, 2013a). Exposure occurs in the general population and in occupational settings, with sources including mobile phones, wireless network, television, radio, 5G technologies, Bluetooth, microwaves, cooking hobs, industrial heating of materials, radar, anti-theft devices, and MRI (IARC, 2013a). Exposure to mobile phones is ubiquitous, considering that nearly 95% of the population in high-income countries and 49% in low-income countries own a mobile phone (International Telecommunications Union, 2022). Source-exposure matrices for the general population and workers are available (Vila et al., 2016; van Wel et al., 2021).

Cancer in humans


The 2019 Advisory Group report (IARC, 2019a) indicated that results from epidemiological studies published after IARC Monographs Volume 102 were mixed (Benson et al., 2013; Hardell et al., 2013; Coureau et al., 2014; IARC, 2019a; Röösli et al., 2019). Since the 2019 Advisory Group report (IARC, 2019a), results from the MOBI-Kids study, an international study of brain cancer and the use of EMF technology by children and adolescents (Castaño-Vinyals et al., 2022), the update of the UK Million Women Study (Schüz et al., 2022), and the European Cohort Study of Mobile Phone Use and Health (COSMOS) (Feychting et al., 2024) were published. No increased risk of neuroepithelial brain tumour was found in the MOBI-Kids study (Castaño-Vinyals et al., 2022). In the Million Women Study update, the increased risk for acoustic neuroma reported previously (10+ years use versus never, RR, 2.46; 95% CI, 1.07–5.64) (Benson et al., 2013) was attenuated (10+ years use versus never, RR, 1.32; 95% CI, 0.89–1.96), and no increased risk was found for other cancer subtypes (glioma, glioblastoma, pituitary, eye tumour); however, the exposure assessment was crude. The previous analysis (Benson et al., 2013) reported Ptrend = 0.03 for acoustic neuroma by duration of use, but such an analysis was not reported in the updated publication (Schüz et al., 2022). COSMOS followed 264 574 participants for a median of 7.12 years (recruitment, 2007–2012, in Denmark, Finland, the Netherlands, Sweden, and the UK). For 100 regression-calibrated cumulative hours of calls (country-specific regression-calibrated estimates based on data collected from operators were applied to the self-reported measurements), HRs were 1.00 (95% CI, 0.98–1.02) for glioma, 1.01 (95% CI, 0.96–1.06) for meningioma, and 1.02 (95% CI, 0.99–1.06) for acoustic neuroma (Feychting et al., 2024).

Mobile phone use was associated with increases in overall cancer and NMSC, urinary cancer (in men only), prostate cancer, and vulva cancer, but not brain cancer, in the UK Biobank cohort (Zhang et al., 2024). There was also a significant trend by length of use for NMSC and prostate cancer (Zhang et al., 2024) Concern exists over exposure misclassification, as mobile phone use was captured only at baseline. These findings are not consistent with those of a Danish nationwide cohort study (Schüz et al., 2006).

In IARC Monographs Volume 102 (IARC, 2013a), selection bias and recall bias from case–control studies were noted as being of major concern. Bias analysis available at the time of that evaluation showed that the J-shaped response curve observed in the Interphone study, the largest case–control study on mobile phone use contributing to the evidence published in IARC Monographs Volume 102 (IARC, 2013a), could have been explained by selection bias, leading to underrepresentation of unexposed controls (Vrijheid et al., 2009a). A recent bias analysis using Monte Carlo simulations showed that the J-shaped relation observed in the Interphone study was compatible with a scenario of greater systematic (> 10%) and random error in cases compared with controls, in the absence of any effect (Bouaoun et al., 2024). Validation studies within the Interphone study showed that there was little differential exposure misclassification between cases and controls; however, in heavy users, overestimation was greater in cases than in controls (Vrijheid et al., 2009b).

Cancer in experimental animals

The 2019 Advisory Group report (IARC, 2019a) noted the availability of new data from the large US NTP study that show clear evidence of an increased incidence of malignant schwannoma in the heart (and possibly some evidence of malignant glioma in the brain) in male rats exposed to radiofrequency radiation at frequencies used by mobile phones; however, no clear increased risk was seen in female rats. Some equivocal evidence was observed of increased evidence of malignant glioma in the brain, malignant schwannoma in the heart, and pheochromocytoma in the adrenal medulla (NTP, 2018a, b). An increased risk of schwannoma of the heart observed in male rats exposed to the highest dose was found in an experimental study conducted at the Ramazzini Institute (Falcioni et al., 2018). International studies, aimed to verify the NTP studies, are ongoing in Japan and the Republic of Korea and are expected in 2024 (Ahn et al., 2022). Currently, a systematic review of the effects of RF-EMF on cancer laboratory animals is ongoing as part of a WHO risk assessment project (Mevissen et al., 2022).

Mechanistic evidence

As noted in the 2019 Advisory Group report (IARC, 2019a): “The previous IARC evaluation concluded that there was weak evidence that radiofrequency radiation was genotoxic but that there was no evidence for mutagenicity (IARC, 2013a).” Since then, there have been many new publications on the genotoxicity of RF-EMF radiation, including studies in exposed humans. The formation of micronuclei on buccal mucosal cells was shown in several studies on mobile phone-emitted radiation (Rashmi et al., 2020; Revanth et al., 2020). Other studies found no evidence of micronucleus formation (de Oliveira et al., 2017) or no conclusive evidence for induction of DNA damage or for alterations of the DNA repair capacity in human cells exposed to several frequencies of RF-EMF radiation (Schuermann et al., 2020). In other studies, no effects of RF-EMF exposure on oxidant or antioxidant capacity, apoptosis, or mutations in the TP53 gene were revealed, regardless of the frequency (Khalil et al., 2014; Gulati et al., 2020). The authors of a meta-analysis to investigate whether RF-EMF emitted by mobile phones have genotoxic or cytotoxic effects on the oral epithelium concluded that the evidence for genotoxic effects was weak (Dos Santos et al., 2020). In experimental systems, there is a large body of literature on investigations of the genotoxicity of RF-EMF (Meltz, 2003). A study showed that rat gliomas appear to share some genetic alterations with IDH1 wildtype human gliomas, and rat cardiac schwannomas also harbour mutations in some of the queried cancer genes (Brooks et al., 2024). An independent systematic review of the genotoxicity of RF-EMF in in vitro mammalian models is ongoing (Romeo et al., 2021).

In addition, evidence associated with other KCs is available. For example, chronic exposure to RF-EMF emitted from mobile phones may induce oxidative stress and an inflammatory response in rats (Singh et al., 2020). Currently, a systematic review of the effects of RF-EMF on biomarkers of oxidative stress in vivo and in vitro is ongoing as part of the WHO risk assessment project (Henschenmacher et al., 2022). Several studies have investigated the immunotoxicity of RF-EMF (Yadav et al., 2022). Mobile phone radiofrequency radiation was found to be associated with thyroid gland insufficiency and alterations in serum thyroid hormone levels in exposed humans and in rodents, with a possible disruption in the hypothalamic–pituitary–thyroid axis (Alkayyali et al., 2021).

Summary

Since the last evaluation, there have been several new high-quality studies. Overall, the human cancer evidence is mixed. There is new evidence of carcinogenicity in experimental animals. Since the previous evaluation, there is new mechanistic evidence related to the KCs, especially genotoxicity in experimental systems and in exposed humans. However, several of the genotoxicity studies in exposed humans provided inconsistent results. Thus, the mechanistic available evidence currently available may be inconclusive.

Overall, the new evidence regarding cancer in humans and in experimental animals could support a re-evaluation, although a change in the current classification of the carcinogenicity of RF-EMF is uncertain. The Advisory Group therefore considered an IARC Monographs evaluation of RF-EMF to be warranted but suggests an evaluation in the latter half of the next 5 years, to await the results of ongoing cancer bioassays, which may provide additional mechanistic evidence.

Recommendation: High priority (and ready for evaluation within 5 years)

Open access report:

--o--


In March, 2019, the Advisory Group for the IARC recommended that the IARC review the research on RFR to determine if it is a carcinogenic hazard (i.e. Group 2A or Group 1). The advisory group recommended that this review be conducted within the next five years and called it a "high priority."

Following are excerpts from the IARC report:

International Agency for Research on Cancer (IARC). Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024. IARC, World Health Organization, 2019. https://monographs.iarc.fr/wp-content/uploads/2019/10/IARCMonographs-AGReport-Priorities_2020-2024.pdf.


Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024

Introduction (pp. 1-2)

"An IARC Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 met in Lyon, France, on 25–27 March 2019. IARC periodically convenes such Advisory Groups to ensure that the Monographs evaluations reflect the current state of scientific evidence relevant to carcinogenicity.

Before the meeting, IARC solicited nominations of agents via the website of the IARC Monographs programme and the IARC RSS news feed, and through direct contact with the IARC Governing Council and members of the IARC Scientific Council, WHO headquarters and regional offices, and previous participants in the Monographs programme. Nominations were also developed by IARC personnel, including the recommended priorities remaining from a similar Advisory Group meeting convened in 2014 (Straif et al., 2014), and the priorities nominated by the Advisory Group.

The list of Advisory Group members and all other meeting participants is provided in Annex 1 (see https://monographs.iarc.fr/wp-content/uploads/2019/02/AGP-ListofParticipants.pdf ) ...."

"Priority was assigned on the basis of (i) evidence of human exposure and (ii) the extent of the available evidence for evaluating carcinogenicity (i.e. the availability of relevant evidence on cancer in humans, cancer in experimental animals, and mechanisms of carcinogenesis to support a new or updated evaluation according to the Preamble to the IARC Monographs). Any of the three evidence streams could alone support prioritization of agents with no previous evaluation. For previously evaluated agents, the Advisory Group considered the basis of the previous classification as well as the potential impact of the newly available evidence during integration across streams (see Table 4 in the Preamble to the IARC Monographs). Agents without evidence of human exposure or evidence for evaluating carcinogenicity were not recommended for further consideration."

....

"Non-ionizing radiation (radiofrequency) and extremely low-frequency magnetic fields (pp. 148-149)

Radiofrequency electromagnetic fields (RF-EMF) were evaluated by the IARC Monographs as possibly carcinogenic to humans (Group 2B) (IARC, 2013e), on the basis of limited evidence of an increased risk of glioma. Extremely low-frequency magnetic fields (ELF-MF) were evaluated as possibly carcinogenic to humans (Group 2B) (IARC, 2002), on the basis of limited evidence of an increased risk of childhood leukaemia.

Exposure Data

Human exposures to RF-EMF can occur from use of personal devices (e.g. cell phones, cordless phones, and Bluetooth) and from environmental sources such as cell phone base stations, broadcast antennas, and medical applications. More than 5 billion people now have access to cell phone devices, and the technology is constantly evolving. Use has also expanded rapidly in low- and middle-income countries, where more than 75% of adults now report owning a cell phone; in high-income countries, the proportion is 96% (Pew Research Center, 2018).

Cancer in Humans

Since the previous IARC Monographs evaluation, several new epidemiological studies have been published on the association between RF-EMF and cancer, although the evidence remains mixed. In the Million Women Study cohort, there was no evidence of increased risk of glioma or meningioma, even among long-term users. There was an increased risk of acoustic neuromas with long-term use and a significant dose–response relationship (Benson et al., 2013). Updated follow-up in the Danish nationwide subscribers study did not find increased risks of glioma, meningioma, or vestibular schwannoma, even among those with subscriptions of 10 years or longer (Frei et al., 2011; Schüz et al., 2011). New reports from case–control studies that assessed long-term use also found mixed results; for example, increased risks of glioma and acoustic neuroma were reported by Hardell & Carlberg (2015) and Hardell et al. (2013), but no evidence of increased risks for these tumours were reported by Yoon et al. (2015) and Pettersson et al. (2014). Röösli et al. (2019) recently reviewed these new data. Several large-scale studies are still in progress and should report results within the next few years. Mobi-Kids is a multicentre case–control study of brain tumours in those aged 10–24 years. Cohort Study of Mobile Phone Use and Health (COSMOS) is a new European cohort of adult cell phone users. There will also be updated results from the Million Women Study.

Cancer in Experimental Animals

New data in experimental animals for exposure to RF-EMF have been published since the previous IARC Monographs evaluation. The large study by the United States National Toxicology Program found an increased risk of malignant schwannomas of the heart in male rats with high exposure to radiofrequency radiation at frequencies used by cell phones, as well as possible increased risks of certain types of tumours in the brain and adrenal glands, but no increased risks in mice or female rats (NTP, 2018a, b). Another study in experimental animals also found an increase in schwannomas of the heart in highly exposed male rats and a possible increase in gliomas in female rats (Falcioni et al., 2018).

 Mechanistic Evidence

The previous IARC evaluation concluded that there was weak evidence that radiofrequency radiation was genotoxic but that there was no evidence for mutagenicity (IARC, 2013e). Although there have been many new publications from a wide variety of experiments, uncertainty remains about the mechanisms, and there are few systematic reviews of the new data (Kocaman et al., 2018).

Although a future evaluation could be broadened to consider exposure to all non-ionizing radiation (including ELF-MF), ELF-MF were evaluated by IARC as possibly carcinogenic to humans (Group 2B), and the Advisory Group did not recommend an update, because of a lack of new informative epidemiological findings, no toxicological evidence, and little supporting mechanistic evidence.

References

The following key references were also identified: Coureau et al. (2014); Carlberg & Hardell (2015); Pedersen et al. (2017).

Recommendation for non-ionizing radiation (radiofrequency): High priority (and ready for evaluation within 5 years)

Recommendation for extremely low-frequency magnetic fields: No evaluation "

References cited in this section of the report:

Benson VS, Pirie K, Schüz J, Reeves GK, Beral V, Green J; Million Women Study Collaborators (2013). Mobile phone use and risk of brain neoplasms and other cancers: prospective study. Int J Epidemiol. 42(3):792–802. https://doi.org/10.1093/ije/dyt072 PMID:23657200

Carlberg M, Hardell L (2015). Pooled analysis of Swedish case-control studies during 1997-2003 and 2007-2009 on meningioma risk associated with the use of mobile and cordless phones. Oncol Rep. 33(6):3093–8. https://doi.org/10.3892/or.2015.3930 PMID:25963528

Coureau G, Bouvier G, Lebailly P, Fabbro-Peray P, Gruber A, Leffondre K, et al. (2014). Mobile phone use and brain tumours in the CERENAT case-control study. Occup Environ Med. 71(7):514–22. https://doi.org/10.1136/oemed-2013-101754 PMID:24816517

Falcioni L, Bua L, Tibaldi E, Lauriola M, De Angelis L, Gnudi F, et al. (2018). Report of final results regarding brain and heart tumors in Sprague-Dawley rats exposed from prenatal life until natural death to mobile phone radiofrequency field representative of a 1.8 GHz GSM base station environmental

Frei P, Poulsen AH, Johansen C, Olsen JH, Steding-JessenM, Schüz J (2011). Use of mobile phones and risk of brain tumours: update of Danish cohort study. BMJ. 343:d6387. https://doi.org/10.1136/bmj.d6387 PMID:22016439

Hardell L, Carlberg M (2015). Mobile phone and cordless phone use and the risk for glioma - analysis of pooled case-control studies in Sweden, 1997-2003 and 2007-2009. Pathophysiology. 22(1):1–13. https://doi.org/10.1016/j.pathophys.2014.10.001 PMID:25466607

IARC (2013e). Non-ionizing radiation, Part 2: Radiofrequency electromagnetic fields. IARC Monogr Eval Carcinog Risks Hum. 102:1–460. Available from: http://publications.iarc.fr/126 PMID:24772662

Kocaman A, Altun G, Kaplan AA, Deniz ÖG, Yurt KK, Kaplan S (2018). Genotoxic and carcinogenic effects of non-ionizing electromagnetic fields. Environ Res. 163:71–9. https://doi.org/10.1016/j.envres.2018.01.034 PMID:29427953

NTP (2018a). Toxicology and carcinogenesis studies in B6C3F1/N mice exposed to whole-body radio frequency radiation at a frequency (1900 MHz) and modulations (GSM and CDMA) used by cell phones. Natl Toxicol Program Tech Rep Ser. 596. Research Triangle Park (NC), USA: US Department of Health and Human Services, Public Health Service. Available from: https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr596_508.pdf.

NTP (2018b). Toxicology and carcinogenesis studies in Hsd:Sprague Dawley SD rats exposed to whole-body radiofrequency radiation at a frequency (900MHz) and modulations (GSM and CDMA) used by cellphones. Natl Toxicol Program Tech Rep Ser. 595. Research Triangle Park (NC), USA: US Department of Health and Human Services, Public Health Service. Available from: https://www.niehs.nih.gov/ntp-temp/tr595_508.pdf.

Pedersen C, Poulsen AH, Rod NH, Frei P, Hansen J, Grell K, et al. (2017). Occupational exposure to extremely low-frequency magnetic fields and risk for central nervous system disease: an update of a Danish cohort study among utility workers. Int Arch Occup Environ Health. 90(7):619–28. https://doi.org/10.1007/s00420-017-1224-0 PMID:28429106

Pettersson D, Mathiesen T, Prochazka M, Bergenheim T, Florentzson R, Harder H, et al. (2014). Long-term mobile phone use and acoustic neuroma risk. Epidemiology. 25(2):233–41. https://doi.org/10.1097/EDE.0000000000000058 PMID:24434752

Pew Research Center (2018). Social media use continues to rise in developing countries, but plateaus across developed ones. Available from: https://www.pewglobal.org/2018/06/19/social-media-use-continues-to-rise-in-developing-countries-but-plateaus-across-developed-ones/

Schüz J, Steding-JessenM, Hansen S, Stangerup SE, Cayé-Thomasen P, Poulsen AH, et al. (2011). Long-term mobile phone use and the risk of vestibular schwannoma: a Danish nationwide cohort study. Am J Epidemiol. 174(4):416–22. https://doi.org/10.1093/aje/kwr112 PMID:21712479

Straif K, Loomis D, Guyton K, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al. (2014). Future priorities for the IARC Monographs. Lancet Oncol. 15(7):683–4. https://doi.org/10.1016/S1470-2045(14)70168-8

Yoon S, Choi J-W, Lee E, An H, Choi HD, KimN (2015). Mobile phone use and risk of glioma: a case-control study in Korea for 2002-2007. Environ Health Toxicol. 30:e2015015. https://doi.org/10.5620/eht.e2015015 PMID:26726040

--o--


In May, 2011, the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, classified radio frequency radiation (RFR) as "possibly carcinogenic to humans (Group 2B), based on an increased risk for glioma, a malignant type of brain cancer, associated with wireless phone use." "The conclusion means that there could be some risk, and therefore we need to keep a close watch for a link between cell phones and cancer risk."

A working group of 31 scientists from 14 nations made this determination after reviewing hundreds of studies that examined the potential carcinogenic hazard of long-term exposure to RFR. They examined exposure data, studies of cancer in humans, studies of cancer in experimental animals, and mechanistic and other relevant data. 

" 'Given the potential consequences for public health of this classification and findings,' said IARC Director Christopher Wild, 'it is important that additional research be conducted into the long‐term, heavy use of mobile phones. Pending the availability of such information, it is important to take pragmatic measures to reduce exposure such as hands‐free devices or texting.' "


IARC (2011). "IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans." Press Release No. 208. IARC, WHO. https://www.iarc.fr/wp-content/uploads/2018/07/pr208_E.pdf

IARC (2013e). Non-ionizing radiation, Part 2: Radiofrequency electromagnetic fields. IARC Monogr Eval Carcinog Risks Hum. 102:1–460. Available from: http://publications.iarc.fr/126 PMID:24772662

For a summary of this 2013 monograph see: